PRKAA1 and pulmonary fibrosis: To determine whether CRBN mediates lung fibrosis by inactivating AMPKα1, we tested the effect of metformin (a pharmaceutical activator of AMPK) on TGF-β1-induced activation of the SMAD pathway and collagen deposition in CRBN-overexpressing cells.